Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Proliferative Diabetic Retinopathy (PDR) Market Size During 2025–2029?
The market for proliferative diabetic retinopathy (pdr) has experienced swift expansion over recent years. This market is projected to expand from $2.42 billion in 2024 to $2.69 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.3%. Historically, this growth stems from factors such as increasing diabetes prevalence, shifts in lifestyle coupled with the consumption of unhealthy diets, various government initiatives, and a rising incidence of diabetes-related vision loss.
The proliferative diabetic retinopathy (pdr) market size is anticipated to undergo rapid expansion over the next few years. It is forecast to reach $4.03 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. This projected growth during the forecast period can be attributed to several factors, including an aging population, increased public awareness and education concerning diabetes, greater funding for research and development, and a rising demand for combination therapies. Significant trends during the forecast period are expected to encompass advancements in diagnostic technologies, innovations in treatment options, the utilization of artificial intelligence (AI) for early diagnosis, progress in gene therapy, and sophisticated retinal imaging.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12911&type=smp
What Are The Main Drivers Boosting The Proliferative Diabetic Retinopathy (PDR) Industry’s Expansion?
The increasing occurrence of diabetes is projected to boost the expansion of the proliferative diabetic retinopathy (PDR) market. Diabetes, a chronic condition characterized by elevated blood glucose levels, is the primary cause of proliferative diabetic retinopathy, which can be addressed by various methods to prevent further retinal damage and preserve vision. For instance, in June 2024, the UK’s National Health Service (NHS) reported a rise in diabetes cases among individuals under 40, increasing from 173,166 in 2022 to 216,440 in 2023. This significant growth highlights a concerning trend of rapidly escalating diabetes prevalence within younger populations. Consequently, the rising prevalence of diabetes is a key driver for the proliferative diabetic retinopathy (PDR) market.
Which Key Segments Fueling The Proliferative Diabetic Retinopathy (PDR) Market?
The proliferative diabetic retinopathy (pdr)market covered in this report is segmented –
1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy; Intraocular Steroids; Laser Surgery; Vitrectomy
2) By Mode of Administration: Injectables; Oral; Other Mode Of Administrations
3) By Application: Hospitals; Clinics; Other Applications
Subsegments:
1) By Anti-VEGF Therapy: Aflibercept; Ranibizumab; Bevacizumab
2) By Intraocular Steroids: Triamcinolone Acetonide; Dexamethasone Implant; Fluocinolone Acetonide
3) By Laser Surgery: Focal Laser Photocoagulation; Panretinal Laser Photocoagulation
4) By Vitrectomy: Pars Plana Vitrectomy; Anterior Vitrectomy
Which Trends Are Impacting The Proliferative Diabetic Retinopathy (PDR) Market?
Companies operating in the proliferative diabetic retinopathy market are consistently focused on developing innovative therapies to enhance treatment effectiveness, reduce patient burden, and improve patient outcomes. As an example, in June 2022, Biogen, a US-based biotechnology company, alongside Samsung Bioepis, a South Korea-based biotech company, introduced Byooviz (ranibizumab-nuna), marking it as the first ophthalmology biosimilar in the US. This product is employed to treat individuals with diabetic macular edema, proliferative diabetic retinopathy, neovascular age-related macular degeneration (wet AMD), and choroidal neovascularization.
Who Are The Key Multinational Companies Dominating The Proliferative Diabetic Retinopathy (PDR) Market?
Major companies operating in the proliferative diabetic retinopathy (pdr) market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, Kubota Vision Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Santen Pharmaceutical Co. Ltd., Lupin Limited, Genentech Inc., Sirnaomics Inc.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Proliferative Diabetic Retinopathy (PDR) Industry?
North America was the largest region in the proliferative diabetic retinopathy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in proliferative diabetic retinopathy (PDR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Proliferative Diabetic Retinopathy (PDR) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12911&type=smp
Browse Through More Reports Similar to the Global Proliferative Diabetic Retinopathy (PDR) Market 2025, By The Business Research Company
Digital Diabetes Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report
Diabetes Care Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report
Pet Diabetes Care Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model